TrialClinical cancer research : an official journal of the American Association for Cancer Research2012

A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck.

Carol M Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.